Dirceu Barbano reappointed director of Brazil’s Anvisa
This article was originally published in Clinica
Dirceu Barbano has been reappointed as director of Brazilian healthcare regulatory agency Anvisa for a second three-year term. The priorities for the agency during his tenure will be to make it “more efficient without compromising on the rigour that characterises its decision-making”. This will be achieved by “improving the regulatory framework [and through] closer dialogue with society”, he told the Senate’s Social Affairs Commission (CAS), which gave final approval for the appointment. Mr Barbano, a pharmacist, originally joined Anvisa in October 2008, but has been serving as the agency’s director-president since January 2011, when the health ministry was restructured under the change of federal presidency (www.clinica.co.uk, 7 January 2011).
You may also be interested in...
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.